Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Povidoneiodine

Research Leaders

5 sponsors active, led by M.D. Anderson Cancer Center

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed3
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT06075836Completed

AI Assisted Detection of Chest X-Rays

NCT05131945Not ApplicableCompleted

GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)

NCT03696524Not ApplicableWithdrawnPrimary

Tunneled Pleural Catheters for Refractory Effusions Attributed to Congestive Heart Failure (TREAT-CHF) Trial

NCT03597828CompletedPrimary

Respiratory Function of Dexmedetomidine in Patients Undergoing Pleuroscopy

NCT02975921Phase 4Withdrawn

Betadine Pleurodesis Via Tunneled Pleural Catheters

Showing all 5 trials

Research Network

Common Treatments

  • Povidoneiodine1
  • Cases Reading1
  • Tunneled Pleural Catheter1
  • Ground Truthing1
  • Gravity Thoracentesis1

Active Sponsors

  • M.D. Anderson Cancer Center1
  • Yale University1
  • University of California, Los Angeles1
  • Attikon Hospital1
  • Oxford University Hospitals NHS Trust1

Top Investigators

Related Conditions

  • Pleural Effusion2
  • Pulmonary Calcification1
  • Thoracentesis1
  • Pneumothorax Acute1
  • Pleural Effusion Malignant1

Activity Timeline